Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 30
|
BSPED2012
|
Next issue
40th Meeting of the British Society for Paediatric Endocrinology and Diabetes
All volumes
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
Speaker Abstracts
CME TRAINING DAY
Physiology and developmental disorders of the pituitary
ea0030s1
Causes, diagnosis and management of pituitary dysfunction
ea0030s2
The surgical management of pituitary tumours
ea0030s3
Genetic disorders of thyroid physiology and development
ea0030s4
Hypothyroidism
ea0030s5
Hyperthyroidism and its management
ea0030s6
MAIN MEETING
Abstract unavailable
ea0030s7
Gender reassignment surgery in GID
ea0030s8
Symposium 2 Controversies in Paediatric Endocrinology
GH in transition
ea0030s9
MEN syndromes - genetics and ethics of screening
ea0030s10
Symposium 3 The Olympiad!
Beyond reasonable doubt: catching the GH cheats
ea0030s11
Physical Activity and Athletic Training in Children and Adolescents
ea0030s12
Symposium 4 Hot Topics in Diabetes
Abstract unavailable
ea0030s13
Continuous age appropriate structured education for children and young people with diabetes
ea0030s14
Symposium 5
Structured Knowledge and Information Programme-the SKIP course
ea0030s15
How paediatric diabetes nurse specialists support schools
ea0030s16
Symposium 6 Diabetes and Sport
Physiology of exercise and endurance sport in type 1 diabetes
ea0030s17
Optimising sports performance in type 1 diabetes
ea0030s18
Keynote Lecture
Insulin pumps and continuous glucose monitoring: the evidence
ea0030s19
ENDOCRINE NURSES DAY
Congenital hyperinsulinism the American experience
ea0030s20
Abstract unavailable
ea0030s21
Endocrine Nurse Session 1
The Bare Bones
ea0030s22
Case Presentation Endocrinology in Sport
Abstract unavailable
ea0030s23
Endocrine Nurse Session 2
Egg and Ovarian tissue preservation. What can we offer to preserve fertility options for the future?
ea0030s24
Oral Communications
Oral Communications 1
Iodine status in UK pregnant women and implications for fetal brain development
ea0030oc1.1
Disease- and treatment-related factors implicated in late neuroendocrine morbidity after paediatric optic pathway gliomas: a preliminary multivariate analysis of 96 patients treated over 30 years
ea0030oc1.2
Potential novel insights into the control of the feto-placental unit by kisspeptin
ea0030oc1.3
Skeletal effects of hypothyroidism are mediated by thyroid hormone receptor [alpha]
ea0030oc1.4
Ethnic differences in vascular growth factor levels in early life in relation to arterial stiffness in the Manchester heart and growth study
ea0030oc1.5
A novel syndrome characterized by hypothalamic hormonal insufficiency, neonatal seizures, congenital abnormalities of the kidneys and urinary tract and obesity due to mutation in a gene regulating hypothalamic development
ea0030oc1.6
Novel therapies herald novel diseases: The first paediatric case series of Graves' immune reconstitution disease
ea0030oc1.7
Loss-of-function mutations in IGSF1 cause a novel, X-linked syndrome of central hypothyroidism and testicular enlargement
ea0030oc1.8
Oral Communications 2
Assessment of adrenal function in female to male adolescents with gender identity dysphoria
ea0030oc2.1
Deficiency of the triple A syndrome gene product, ALADIN, renders human adrenal cells susceptible to oxidative stress with subsequent impact on steroidogenesis
ea0030oc2.2
Does vitamin D modulate mitochondrial oxidative phosphorylation?
ea0030oc2.3
Prenatal dexamethasone for treatment of congenital adrenal hyperplasia: a possible association with late gestational fetal demise in two cases
ea0030oc2.4
Abnormal neurological and developmental outcomes in children with persistent and spontaneously resolving congenital hyperinsulinism
ea0030oc2.5
Childhood body composition is associated with maternal plasma polyunsaturated fatty acids status in late pregnancy
ea0030oc2.6
Growth, GH-IGF1 status and response to r-hGH therapy in 3-M syndrome, related to mutation status
ea0030oc2.7
Genetic screening in a large cohort of patients with congenital hypopituitarism; current knowledge and future directions
ea0030oc2.8
GH neuro-secretory dysfunction following traumatic brain injury in childhood
ea0030oc2.9
When is it justifiable to await venous thyroid function tests before starting thyroxine treatment in infants referred with capillary TSH elevation?
ea0030oc2.10
Oral Communications 3
HbA1c league tables: does selection policy encourage foul play to support promotion to the 'premier league'?
ea0030oc3.1
An audit of the management of diabetic ketoacidosis in children in a large teaching hospital
ea0030oc3.2
Quality of life and HbA1c outcomes in children and young people commencing insulin pump therapy
ea0030oc3.3
Continuous glucose monitoring: are there more barriers than benefits?
ea0030oc3.4
Childhood type I diabetes education at time of diagnosis: what patients want to know
ea0030oc3.5
Oral Communications 4
Metformin in obese children and adolescents: the MOCA trial
ea0030oc4.1
Patterns of presentation and initial management of type I diabetes mellitus in the UK: the early care survey
ea0030oc4.2
White UK children are older, more obese and more insulin resistant than non-White UK children at diagnosis of type 2 diabetes: baseline results of the UK national type 2 diabetes cohort
ea0030oc4.3
Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 protein, which regulates its stability and expression
ea0030oc4.4
The effect of insulin intensification on glycaemic control and lipid levels in children and young persons with type 1 diabetes differs in relation to ethnic group
ea0030oc4.5
Oral Communications 5
Adolescent transition clinic: a review of the young person's self-confidence and future concerns
ea0030oc5.1
Comparison of patient experiences of the glucagon and insulin pituitary provocation tests: time for a reappraisal
ea0030oc5.2
A comparison of patient's preferences for attributes of GH delivery devices: children starting versus children established on GH treatment
ea0030oc5.3
The role of the paediatric endocrine nurse in supporting the information needs of girls with Turner syndrome and their parents
ea0030oc5.4
Poster Presentations
(1)
A homozygous glutathione peroxidase 1 mutation, p. Arg130-Leu133del, in a patient with familial glucocorticoid deficiency
ea0030p1
Outcome of endoscopic transsphenoidal pituitary surgery in four paediatric Cushing's disease patients: a new therapeutic approach
ea0030p2
The accuracy of diagnosing adrenal insufficiency in children undergoing glucagon stimulation test (GST)
ea0030p3
The management of 21-hydroxylase deficiency: a retrospective audit in south east and west of Scotland
ea0030p4
A rare case of virilizing adrenocorical carcinoma in a child presented with peripheral precocious puberty
ea0030p5
The use of GH and anastrazole can help optimise linear growth in congenital adrenal hyperplasia due to CYP11B1 mutations
ea0030p6
Growth and pubertal delay in autoimmune Addison's disease
ea0030p7
The effect of homozygosity versus heterozygosity for IGFALS gene mutations on growth, bone strength and insulin resistance
ea0030p8
Vitamin D trending: trends in vitamin D status, measurement and prescribing in Northern England, 2002-2011
ea0030p9
A case of Noonan syndrome with a SHOC2 mutation associated with cortical and trabecular osteopenia and early onset fragility fractures
ea0030p10
Dietary calcium restriction in idiopathic infantile hypercalcemia does not adversely affect spinal and distal radial bone mineral density: report on nine patients
ea0030p11
An unusual case of hypercalciuria with hypophosphataemia and hyperphosphaturia
ea0030p12
Managing hypercalcaemia in subcutaneous fat necrosis of the newborn
ea0030p13
A neonate with hypocalcaemia caused by co-existing vitamin D deficiency and congenital hypoparathyroidism
ea0030p14
Generalised arterial calcification of infancy
ea0030p15
A case of Camurati-Engelmann disease with endocrine complications due to a missense mutation of the TGFB1 gene
ea0030p16
Acute mesenteric ischaemia: a thrombotic complication of diabetic ketoacidosis?
ea0030p17
The Euro-WABB Registry: differences in prevalence of diabetes between Wolfram, Alstrom, and Bardet-Biedl syndromes
ea0030p18
Adolescent diabetes and emerging adulthood: effectiveness of a robust and staged joint-care transition pathway
ea0030p19
Uptake of 2009 BSPED guidelines in Northern East England and North Cumbria
ea0030p20
Pigmentary hypertrichosis and non-autoimmune insulin dependent diabetes mellitus syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome
ea0030p21
Newly diagnosed type 1 diabetes: similarities and differences in initial management guidelines
ea0030p22
Results from 23 years of continuous diabetes audit
ea0030p23
Severe hypercalcaemia secondary to severe, prolonged metabolic acidosis in a patient with DKA
ea0030p24
Review of guidelines for the management of children and adolescent with diabetes requiring surgery in three regions of England
ea0030p25
Co-morbidities in children and young people with type 1 diabetes: who is responsible for management?
ea0030p26
Cerebral oedema in toddlers; risks and challenges: a case series
ea0030p27
Improvement in HbA1c following change from three times daily injections to a basal bolus insulin regimen in the Lothian paediatric diabetes population
ea0030p28
Should we check vitamin D status at time of diagnosis of type 1 diabetes mellitus?
ea0030p29
Audit of diabetic ketoacidosis management in adolescents in paediatric and adult care settings
ea0030p30
Type 1 diabetes in a child with aplastic anaemia
ea0030p31
Gonadotropin independent precocious puberty associated with later diagnosis of testicular embryonal carcinoma
ea0030p32
Karyotype-phenotype correlations in height and pubertal outcomes of Turners patients
ea0030p33
Abnormal glucose homeostasis in survivors of childhood acute lymphoblastic leukaemia treated with total body irradiation and bone marrow transplantation is associated with increased visceral and intramuscular fat
ea0030p34
Late endocrine effects of non-craniopharyngioma, non-glioma brain tumours: descriptive analyses of patients referred to late-effects service
ea0030p35
Audit of endocrine late effects in survivors of childhood brain tumours
ea0030p36
Long-term morbidity after traumatic brain injury in childhood: fatigue, impact on cognition, health related quality of life and abnormal GH status
ea0030p37
Cushing's syndrome due to POMC secretion from an abdominal yolk sac tumour in a 2 year old child
ea0030p38
The impact of malaria in pregnancy on changes in blood pressure in children over the first year of life
ea0030p39
Diagnostic yield in chondrodysplasias: a single centre study between 2002 and 2012
ea0030p40
Two hour insulin/C peptide levels in oral glucose test: are they really necessary?
ea0030p41
Feasibility of measuring birth length and parental height for small babies and following-up short children at 2 years
ea0030p42
Prevalence and diagnosis of cholesteatoma in Turner syndrome
ea0030p43
Risk factors for short term post-operative complications after pancreatectomy for congenital hyperinsulinism
ea0030p44
Hyperinsulinaemic hypoglycaemia in newborn twins
ea0030p45
Extraction of high quality RNA from fresh frozen and formalin fixed paraffin embedded human pancreatic tissues samples of patients with congenital hyperinsulinism for gene expression microarray
ea0030p46
Beckwith-Wiedemann syndrome with paternally inherited duplication of chromosome 11p and a deletion of the long arm of chromosome 11
ea0030p47
Comparing common methods of body composition assessments with magnetic resonant imaging in patients at high risk of sarcopenia and abnormal body proportions
ea0030p48
Mind over muscle: investigating the biology of fatigue in GH deficiency using 31P-MRS
ea0030p49
Adiponectin levels are inversely related to length in early infancy
ea0030p50
Growth and glucose homeostasis after 2 years in children with inflammatory bowel disease receiving recombinant GH therapy for growth retardation
ea0030p51
Puberty phases: an evaluation of a new system for rating puberty in paediatric practice
ea0030p52
High rates of non adherence to daily r-hGH injections revealed by the easypod electronic dose record
ea0030p53
Management of childhood-onset GH deficiency in young adulthood
ea0030p54
Outcomes of paediatric craniopharyngioma: a single centre experience
ea0030p55
Human GH (somatotropin) for growth failure in children
ea0030p56
Grave problem, unrelated to fracture
ea0030p57
Key efficacy issues in the use of recombinant human GH in children with prader-willi syndrome
ea0030p58
Assessment of endocrinological, ophthalmological and radiological abnormalities in the irish paediatric cohort of septo-optic dysplasia
ea0030p59
Septo-optic dysplasia and X-linked adrenoleukodystrophy: two rare conditions presenting together
ea0030p60
A prospective study of pubertal growth in children with inflammatory bowel disease
ea0030p61
Audit of children with thyrotoxicosis treated with antithyroid drugs by block and replacement regime: relapse rate and outcomes
ea0030p62
A regional survey of postnatal management of babies at risk of neonatal thyrotoxicosis
ea0030p63
Rhabdomyolysis and hypoglycaemia in profound hypothyroidism
ea0030p64
Thyroid Hormone resistance: a case report
ea0030p65
A case of GH deficiency?
ea0030p66